Skip to search formSkip to main contentSkip to account menu

SR 13668

Known as: SR-13668, SR13668 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Potency and activity of SR13668 in cancer prevention have been proven in several in vitro and in vivo cancer models. However, the… 
2012
2012
SR13668 [2,10-Dicarbethoxy-6-methoxy-5,7-dihydro-indolo-(2,3-b)carbazole] has been proven effective in cancer prevention, but the… 
2012
2012
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Chemopreventive compound SR13668 showed promising… 
2011
2011
SR13668, an orally active Akt pathway inhibitor, has demonstrated cancer chemopreventive potential in preclinical studies. To… 
2011
2011
SR13668, an orally active cancer therapeutic agent, exhibits potent antitumor activity against various human cancer xenografts (e… 
2011
2011
SR13668, an orally active Akt pathway inhibitor, has demonstrated cancer chemopreventive potential in preclinical studies. To… 
2010
2010
Purpose: SR13668, an orally active AKT pathway inhibitor, has demonstrated cancer chemopreventive potential in preclinical… 
2006
2006
PURPOSE Ex vivo expansion of limbal epithelial progenitor cells on amniotic membrane (AM) without 3T3 fibroblasts is a new…